London private GLP-1 clinics May 2026: who's actually prescribing this week
The London private GLP-1 market has fragmented since the NHS Wegovy expansion in late 2025. Here's the current operational state of who's prescribing, what they charge, and which path is wrong for whom.
The London private GLP-1 landscape changed materially after the NHS Wegovy expansion in late 2025. The patient who would have gone private a year ago now has an NHS path that didn't exist; the patient who can't get on the NHS path needs to navigate a private market that's lost some of its pricing leverage. Here's the current shape.
For the broader UK picture see the UK GLP-1 buyer's guide and the May 2026 NHS update. This post is specifically about the London private clinic ecosystem and who's actually filling scripts in the current week.
Who you're actually competing with
The current London private GLP-1 market splits into roughly four operator types:
Established Harley Street weight management clinics. Long-running, premium-positioned, full clinical workup, doctor-led prescribing. Names you'll see: Royal Free's private wing, Cromwell Hospital, London Bridge Hospital private, plus a constellation of smaller Harley Street operators. Pricing in the 350-550 GBP per month range for brand Mounjaro at 5mg, plus consultation fees of 200-400 GBP.
Telehealth UK platforms with London prescribers. Numan, Voy, Boots Online Doctor, Superdrug Online Doctor, Lloyds Direct, Manual. Pricing in the 200-350 GBP per month range. Workflow is online consultation, prescription dispatched via UK pharmacy. Some have in-person London options as upsells.
Lower-cost private GP networks. Babylon-style, Push Doctor, MyHealthcare, plus smaller online GP services. Generally 150-250 GBP per month at 5mg. Less specialized in weight management; broader generalist GPs prescribing GLP-1s.
Cosmetic and wellness clinics. A growing segment of dermatology and aesthetic clinics now offer GLP-1 prescriptions. Quality varies meaningfully; some are excellent, some are pure-revenue plays. Pricing erratic.
What changed in the last 12 months
NHS expansion ate the lower end of the private market. Patients with BMI 35+ and one comorbidity now have a real NHS path for Wegovy starting from June 2026 (announced in cycle #28). A meaningful slice of patients who previously went private have now gotten on the NHS list. The private market that remains is patients who don't qualify, or who can't wait the 6-9 month NHS waiting list, or who want tirzepatide specifically (NHS path is Wegovy-only).
Tirzepatide private prescribing became standard. Tirzepatide approval and supply normalization in the UK throughout 2025 means most private clinics now stock both Wegovy and Mounjaro/Zepbound. The "we only have Wegovy" pattern from 18 months ago is gone.
Compounded tirzepatide remained limited. Unlike the US, UK private clinics largely don't compound GLP-1s; the regulatory environment and the smaller market make it less common. A few specialist pharmacies do compounding for specific patient situations, but the typical London private clinic is dispensing brand pharmaceutical.
Pricing compressed at the budget end. Telehealth competition has pushed monthly costs down at the budget tier. Mid-2024 pricing of 350-450 GBP for telehealth Mounjaro is now 200-300 GBP. The premium tier (Harley Street, in-person) hasn't dropped meaningfully.
Who's actually prescribing this week
The operators most reliably prescribing as of mid-May 2026:
Telehealth, generalist: Numan, Voy, Manual, Boots Online Doctor. Most reliable for Wegovy; tirzepatide variable but improving.
Telehealth, specialist: Found, Juniper UK, Galen Health, Eucalyptus brands. More structured weight-management workflow including metabolic labs and ongoing followup.
In-person London, mid-tier: A growing number of GP-led weight management clinics in zones 1-3. The London Weight Management Clinic, ProSlim London, several others. These don't have nationally recognizable brands but are reliably prescribing.
In-person London, premium: The Cadogan Clinic, Cromwell Hospital weight management, London Bridge Hospital private. Premium pricing for premium environments.
Boots and Superdrug pharmacy chains: Each has its own online doctor service with reliable Wegovy stock and increasingly tirzepatide stock. Lower-friction for patients who already use these chains.
What the prescription actually looks like
Most London private GLP-1 paths have these in common:
- Initial intake form covering weight, BMI, medical history, current medications
- A prescriber consultation (video, phone, or in-person depending on platform)
- Lab requirements vary; some require pre-prescription bloods, some don't
- Prescription dispatched via UK-licensed pharmacy
- Monthly refills that may or may not require additional consultations
What varies meaningfully:
Followup intensity. Specialist weight-management clinics offer monthly check-ins with measurable touchpoints. Generalist telehealth platforms often see you once and then renew the prescription month after month with minimal touchpoint.
Side-effect handling. A premium clinic with structured followup will catch side effects early and adjust. A budget telehealth platform may not have a workflow for the patient who's struggling at week 6.
Prescriber continuity. Some platforms route you through a different prescriber every month; some maintain a single named prescriber. Continuity matters more for complicated cases than for straightforward ones.
What I'd actually pick for different cases
Healthy adult with no medical complications, just wants Mounjaro at the lowest reasonable price: A reputable telehealth specialist (Found, Juniper UK, Galen). 200-280 GBP per month, structured followup, decent prescriber continuity.
Adult with co-morbidities (T2D, hypertension, sleep apnea, etc): In-person clinic with structured medical workup. Either a London Weight Management-style mid-tier or a Harley Street premium option depending on budget. The integrated care matters when other conditions are interacting with the GLP-1.
Adult who has tried and failed on a budget telehealth platform: Move up to a specialist, in-person or telehealth. The "you took it for 8 weeks, lost 4 pounds, and feel like it's not working" pattern is often a workflow failure, not a drug failure.
Adult who wants the cheapest legitimate option: Boots or Superdrug online doctor. Mainstream pharmacy chains, reliable supply, English-language workflow, 200-260 GBP per month range.
What I wouldn't recommend
The cosmetic-and-wellness clinic tier is highly variable and hard to filter without doing significant work. Some are excellent; some are paying 30-50% margins on a flipped prescription with no clinical workup worth speaking of. The Panya scoring rubric was designed for this kind of variability, but most patients are better served by the named tiers above.
For pricing comparison and current state on supply, the Panya UK vendor catalog holds the live state. The blog post numbers age fast; the catalog updates monthly.
One email a week. Catalog updates, new posts, BKK supply state. No spam, no MLM. What lands in the inbox →
We earn a small commission when you buy through recommended vendors. That is how this stays free. Vendors rank by quality signals, not paid placement.
Mira Tanaka is the editor at panya, based in Bangkok. Editor at Panya. Covers peptide therapeutics with a focus on the routing decisions mainstream adults actually face. Corrections, tips, or push-back: editor@panya.health.
Bangkok GLP-1 starter: the expat-and-tourist guide to getting tirzepatide in Thailand
Bangkok is the lowest-friction GLP-1 access point in Asia for English-speaking adults. Here's the complete map: which clinics actually fill scripts for foreigners, what they charge, what to bring, what to expect.
Bangkok tirzepatide price comparison May 2026: actual numbers from 8 clinics
The real Bangkok price spread for brand Mounjaro and compounded tirzepatide as of May 2026, ranked from cheapest to most expensive, with the consultation fees and delivery options that change the math.
DEXA scans on tirzepatide: what body composition actually shows at 6 months
The scale tells you weight. DEXA tells you what you're actually losing. The patterns at 3, 6, and 12 months on tirzepatide are more nuanced than the trial averages suggest.